NCT01064336View on ClinicalTrials.gov

Promacta Pregnancy Registry

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

Eltrombopag

Eltrombopag is an orally bioavailable, small molecule thrombopoietin receptor (TPO-R) agonist for the treatment of idiopathic thrombocytopenic purpura